A 96-week, two-arm, randomized, single-masked, multicenter, phase III study assessing the efficacy and safety of brolucizumab 6 mg compared to panretinal photocoagulation laser in patients with proliferative diabetic retinopathy (CONDOR)
2022-06-27
عنوان الدراسة
A 96-week, two-arm, randomized, single-masked, multicenter, phase III study assessing the efficacy and safety of brolucizumab 6 mg compared to panretinal photocoagulation laser in patients with proliferative diabetic retinopathy (CONDOR)
داعم الدراسة
Novartis
دواء الدراسة
Brolucizumab
رقم بروتوكول الدراسة
CRTH258D2301
حالة الدراسة
Completed
موقع الدراسة
DESH
مرحلة الدراسة
3
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。